candesartan has been researched along with Focal Segmental Glomerulosclerosis in 6 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We subsequently used full dose ramipril, candesartan and aliskiren under a close monitoring of kidney function and electrolytes and examined the effect on proteinuria, clinical course and tolerability over 12 months." | 3.75 | Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation. ( Amann, K; Frank, H; Freiberger, V; Heemann, U, 2009) |
| "We report here a case of type I diabetes mellitus with secondary FGS accompanied by proteinuria 10 months following kidney transplantation." | 1.33 | Secondary focal segmental glomerulosclerosis following kidney transplantation in a patient with type I diabetes mellitus. ( Hosoya, T; Mitome, J; Miyazaki, Y; Tanno, Y; Utsunomiya, Y; Yamaguchi, Y; Yamamoto, H; Yamamoto, I, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freiberger, V | 1 |
| Amann, K | 1 |
| Heemann, U | 2 |
| Frank, H | 1 |
| Yamamoto, I | 1 |
| Yamamoto, H | 1 |
| Mitome, J | 1 |
| Tanno, Y | 1 |
| Utsunomiya, Y | 1 |
| Miyazaki, Y | 1 |
| Yamaguchi, Y | 1 |
| Hosoya, T | 1 |
| Krämer, S | 1 |
| Kron, S | 1 |
| Wang-Rosenke, Y | 1 |
| Loof, T | 1 |
| Khadzhynov, D | 1 |
| Morgera, S | 1 |
| Kawachi, H | 1 |
| Shimizu, F | 2 |
| Martini, S | 1 |
| Neumayer, HH | 1 |
| Peters, H | 1 |
| Hamar, P | 1 |
| Peti-Peterdi, J | 1 |
| Rázga, Z | 1 |
| Kovács, G | 1 |
| Rosivall, L | 1 |
| Taal, MW | 1 |
| Brenner, BM | 1 |
| Obata, J | 1 |
| Nakamura, T | 1 |
| Takano, H | 1 |
| Naito, A | 1 |
| Kimura, H | 1 |
| Yoshida, Y | 1 |
| Guo, DF | 1 |
| Inagami, T | 1 |
1 review available for candesartan and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
ACE-I vs angiotensin II receptor antagonists: prevention of renal injury in chronic rat models.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensiv | 1999 |
5 other studies available for candesartan and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation.
Topics: Adult; Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; An | 2009 |
Secondary focal segmental glomerulosclerosis following kidney transplantation in a patient with type I diabetes mellitus.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidaz | 2006 |
Rosuvastatin is additive to high-dose candesartan in slowing progression of experimental mesangioproliferative glomerulosclerosis.
Topics: Animals; Benzimidazoles; Biphenyl Compounds; Disease Models, Animal; Disease Progression; Drug Thera | 2008 |
Coinhibition of immune and renin-angiotensin systems reduces the pace of glomerulosclerosis in the rat remnant kidney.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cholesterol; D | 1999 |
Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats.
Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Antihypertensive Agents; Benzimidazoles; Biph | 2000 |